This flow chart depicts pathways from intimate partner violence to HIV. There are two entry points to the flowchart: IPV and perpetrator factors.
From the IPV entry point: IPV leads to sexual assault and psychological distress. Psychological distress leaves to …
The diagram depicts complex, mono-directional relationships between 27 factors related to antiretroviral (ARV) use among Indigenous peoples living in Saskatchewan. The 27 factors connect to each other as well as to three central nodes: Access to ARV therapy, …
This bar graph demonstrates the gap between the 2014 HIV care cascade in Ontario and the 90-90-90 targets set by UN AIDS.
The first bar, which represents all people living with HIV in Ontario is set to 100% and serves …
Behavioural and other non-pharmacological therapies have a potential role in managing HIV associated cognitive impairment, as Dr. Jose Muñoz-Moreno, of Spain’s Lluita contra la SIDA Foundation, outlined in this presentation.
Cognitive …
Dr. Robbins of Columbia University shared his perspective on HIV associated neurocognitive disorder (HAND) diagnostic issues as a clinical psychologist and clinical neuropsychologist, and discussed research on HAND screening tools.
Typically, providers see patients with concerns about …
Ten years ago, few people over 50 were being treated for HIV; today they make up one third of the HIV- positive population. Dr. Alan Winston, with the Department of Medicine at Imperial College of London, noted that this is …
Dr. Claire Kendall, of the University of Ottawa, talked about the opportunities for improving HIV care in Ontario and particularly about the potential for a more integrated model of community care.
We know …
Dr. Eric Cohen is one of the principal investigators of CanCURE, the Canadian HIV Cure Enterprise. CanCURE began in 2013. It aims to understand the persistence of HIV during antiretroviral therapy (ARV) and to …
People living with HIV are getting older due both to extended survival and to an increase in new diagnoses over the age of 50. Dr. …
Ten years ago, few people over 50 were being treated for HIV; today this group makes up about one third of the HIV-positive population. This is due to more effective therapy, and also to more people …
